Literature DB >> 3020092

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.

J F Moreau, M Bonneville, M A Peyrat, A Godard, Y Jacques, C Desgranges, J P Soulillou.   

Abstract

Mechanically harvested lymphocytes invading an irreversibly rejected human kidney allograft were seeded at limiting dilution to calculate the frequency of growing precursors. Optimal growth frequency (1/13) was obtained when Epstein-Barr virus (EBV)-transformed donor B lymphocytes were used as stimulators (D-BLCL) in the presence of interleukin 2 (IL-2). The 55 clones analyzed were all T11+ and T3+, and all expressed DR antigens (45% were T8+ and 55% T4+). Only one clone had a double-labeled (T4+ T8+) surface. All cells proliferated significantly against D-BLCL, although T4+ clones had a significantly shorter average doubling time than T8+ clones. Nearly all T8+ clones were specifically cytotoxic for D-BLCL, while both T4 and T8 did not react against K562, autologous EBV-BLCL, and third-party EBV-BLCL. Detectable IL-2 was found in the culture supernatants of only a minority of clones (all T4+).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020092      PMCID: PMC423705          DOI: 10.1172/JCI112674

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

2.  Identity and cytotoxic capacity of cells infiltrating renal allografts.

Authors:  T B Strom; N L Tilney; C B Carpenter; G J Busch
Journal:  N Engl J Med       Date:  1975-06-12       Impact factor: 91.245

3.  OKT4/8 ratio in the blood and in the graft during episodes of human renal allograft rejection.

Authors:  E von Willebrand
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

Review 4.  Cellular events within the rejecting allograft.

Authors:  N L Ascher; R Hoffman; D W Hanto; R L Simmons
Journal:  Transplantation       Date:  1983-03       Impact factor: 4.939

5.  Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes.

Authors:  J F Moreau; R G Miller
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

6.  Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts.

Authors:  T B Strom; N L Tilney; J M Paradysz; J Bancewicz; C B Carpenter
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

7.  The biologic significance of the mixed lymphocyte kidney culture in humans.

Authors:  D Roth; L Fuller; V Esquenazi; G K Kyriakides; V Pardo; J Miller
Journal:  Transplantation       Date:  1985-10       Impact factor: 4.939

8.  Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts.

Authors:  W W Hancock; N M Thomson; R C Atkins
Journal:  Transplantation       Date:  1983-05       Impact factor: 4.939

9.  Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections.

Authors:  J L Platt; T W LeBien; A F Michael
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

10.  Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.

Authors:  B E Loveland; P M Hogarth; R Ceredig; I F McKenzie
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  7 in total

1.  Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.

Authors:  C Retière; V Prod'homme; B M Imbert-Marcille; M Bonneville; H Vié; M M Hallet
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  The frequency and avidity of committed cytotoxic T lymphocytes (cCTL) for donor HLA class I and class II antigens and their relation with graft vascular disease.

Authors:  N M van Besouw; E H Loonen; L M Vaessen; A H Balk; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

3.  Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.

Authors:  A M Miltenburg; M E Meijer-Paape; M R Daha; L C Paul
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

4.  Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.

Authors:  G Gallot; S Vollant; R Vivien; B Clémenceau; C Ferrand; P Tiberghien; J Gaschet; N Robillard; H Vié
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

5.  Lymphokine-activated killer cells lyse human renal cancer cell lines and cultured normal kidney cells.

Authors:  A M Miltenburg; M E Meijer-Paape; M R Daha; L C Paul
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

6.  Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.

Authors:  M Ferrarini; V Steen; T A Medsger; T L Whiteside
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

7.  Dual T cell receptor beta chain expression on human T lymphocytes.

Authors:  F Davodeau; M A Peyrat; F Romagné; A Necker; M M Hallet; H Vié; M Bonneville
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.